Vor bio reports first quarter 2024 financial results and provides company update

Cambridge, mass., may 09, 2024 (globe newswire) -- vor bio (nasdaq: vor), a clinical-stage cell and genome engineering company, today reported financial results for the three-month period ended march 31, 2024, and provided a business update.
VOR Ratings Summary
VOR Quant Ranking